Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | sphingosine kinase 1 | 0.0717 | 1 | 1 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0429 | 0.4348 | 1 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0429 | 0.4348 | 0.4297 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0429 | 0.4348 | 0.4297 |
Trichomonas vaginalis | AGC family protein kinase | 0.0637 | 0.8425 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0407 | 0.3915 | 0.386 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0717 | 1 | 1 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0637 | 0.8425 | 0.5 |
Giardia lamblia | Kinase, AGC PKA | 0.0412 | 0.4005 | 0.5 |
Entamoeba histolytica | protein kinase 2, putative | 0.0412 | 0.4005 | 0.3951 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.062 | 0.8082 | 0.8064 |
Echinococcus granulosus | nervana 2 | 0.0407 | 0.3915 | 0.386 |
Trichomonas vaginalis | AGC family protein kinase | 0.0637 | 0.8425 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0717 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0212 | 0.009 | 0.0107 |
Brugia malayi | Protein kinase domain containing protein | 0.0637 | 0.8425 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0717 | 1 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0212 | 0.009 | 0.0107 |
Entamoeba histolytica | protein kinase, putative | 0.062 | 0.8082 | 0.8064 |
Echinococcus granulosus | serine threonine protein kinase nrc | 0.0412 | 0.4005 | 0.3951 |
Entamoeba histolytica | protein kinase, putative | 0.0637 | 0.8425 | 0.841 |
Schistosoma mansoni | sphingosine kinase A B | 0.0717 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0637 | 0.8425 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0637 | 0.8425 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0407 | 0.3915 | 0.386 |
Mycobacterium tuberculosis | Conserved protein | 0.0717 | 1 | 0.5 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0407 | 0.3915 | 0.386 |
Entamoeba histolytica | protein kinase, putative | 0.0637 | 0.8425 | 0.841 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.0717 | 1 | 1 |
Echinococcus granulosus | Glutaredoxin protein 5 | 0.0407 | 0.3915 | 0.386 |
Plasmodium vivax | rac-beta serine/threonine protein kinase, putative | 0.0412 | 0.4005 | 0.5 |
Trichomonas vaginalis | AGC family protein kinase | 0.0637 | 0.8425 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0637 | 0.8425 | 1 |
Echinococcus multilocularis | rac serine:threonine kinase | 0.0429 | 0.4348 | 0.4297 |
Toxoplasma gondii | AGC kinase | 0.062 | 0.8082 | 0.5 |
Echinococcus multilocularis | Glutaredoxin protein 5 | 0.0407 | 0.3915 | 0.386 |
Echinococcus multilocularis | serine threonine protein kinase nrc serine threonine protein kinase gad | 0.0412 | 0.4005 | 0.3951 |
Plasmodium falciparum | RAC-beta serine/threonine protein kinase | 0.0412 | 0.4005 | 0.5 |
Echinococcus granulosus | nervana 2 | 0.0407 | 0.3915 | 0.386 |
Trichomonas vaginalis | AGC family protein kinase | 0.023 | 0.0433 | 0.0514 |
Brugia malayi | p70 ribosomal S6 kinase beta | 0.062 | 0.8082 | 0.9589 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0429 | 0.4348 | 0.4297 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase | 0.0412 | 0.4005 | 0.3951 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0407 | 0.3915 | 0.386 |
Echinococcus granulosus | serine/threonine protein kinase | 0.0429 | 0.4348 | 0.4297 |
Trichomonas vaginalis | AGC family protein kinase | 0.0637 | 0.8425 | 1 |
Trypanosoma cruzi | Protein kinase B | 0.0429 | 0.4348 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0429 | 0.4348 | 0.4297 |
Trichomonas vaginalis | AGC family protein kinase | 0.0212 | 0.009 | 0.0107 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0637 | 0.8425 | 0.841 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.